Abstract:DVGs (Defective Viral Genomes) are prevalent in RNA virus infections. In this investigation, we conducted an analysis of high-throughput sequencing data and observed widespread presence of DVGs in SARS-CoV-2. Comparative analysis between SARS-CoV-2 and diverse DNA viruses revealed heightened susceptibility to damage and increased sequencing sample heterogeneity within the SARS-CoV-2 genome. Whole-genome sequencing depth variability analysis exhibited a higher coefficient of variation for SARS-CoV-2, while DVG analysis indicated a significant proportion of recombination sites, signifying notable genome heterogeneity and suggesting that a large proportion of assembled virus particles contain incomplete RNA sequences. Moreover, our investigation explored the sequencing depth and DVG content differences among various strains. Our findings revealed that as the virus evolves, there is a notable increase in the proportion of intact genomes within virus particles, as evidenced by third-generation sequencing data. Specifically, the proportion of intact genome in the Omicron strain surpassed that of the Delta and Alpha strains. This observation effectively elucidates the heightened infectiousness of the Omicron strain compared to the Delta and Alpha strains. We also postulate that this improvement in completeness stems from enhanced virus assembly capacity, as the Omicron strain can promptly facilitate the binding of RNA and capsid protein, thereby reducing the exposure time of vulnerable virus RNA in the host environment and significantly mitigating its degradation. Finally, employing mathematical modeling, we simulated the impact of DVG effects under varying environmental factors on infection characteristics and population evolution. Our findings provide an explanation for the close association between symptom severity and the extent of virus invasion, as well as the substantial disparity in population infection characteristics caused by the same strain under distinct environmental conditions. This study presents a novel approach for future virus research and vaccine development.

Clinical and biological insights from viral genome sequencing

Viral genome sequencing methods: benefits and pitfalls of current approaches

Application of next-generation sequencing technologies in virology

Viral genome sequencing to decipher in-hospital SARS-CoV-2 transmission events

Whole genome sequencing in clinical and public health microbiology

Rapid bacterial genome sequencing: methods and applications in clinical microbiology

Transforming clinical microbiology with bacterial genome sequencing

MINERVA: A Facile Strategy for SARS-CoV-2 Whole-Genome Deep Sequencing of Clinical Samples

Next-Generation Sequencing: a new avenue to understand viral RNA-protein interactions

Blood transcriptomics analysis offers insights into variant-specific immune response to SARS-CoV-2

Transforming clinical virology with AI, machine learning and deep learning: a comprehensive review and outlook

Potential Applications of Human Viral Metagenomics and Reference Materials: Considerations for Current and Future Viruses

Efficient and accurate detection of viral sequences at single-cell resolution reveals putative novel viruses perturbing host gene expression

Low-Input, High-Resolution 5' Terminal Filovirus RNA Sequencing with ViBE-Seq

Unbiased metagenomic detection of RNA viruses for rapid identification of viral pathogens in clinical samples

Translating RNA sequencing into clinical diagnostics: opportunities and challenges

Unveiling Inter- and Intra-Patient Sequence Variability with a Multi-Sample Coronavirus Target Enrichment Approach

Bioinformatic analysis of defective viral genomes in SARS-CoV-2 and its impact on population infection characteristics

Tracking the prevalence and emergence of SARS-CoV-2 variants of concern using a regional genomic surveillance program

Bioinformatic Approaches for Comparative Analysis of Viruses

The Blood Virome: A new frontier in biomedical science